NCT01804374 2015-06-17
SERIO
Italian Sarcoma Group
Phase 2 Completed
Clinical Trials
4 trialsNCT01518413 2015-02-27
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors
Children's National Research Institute
Phase 1 Completed
NCT00330421 2014-04-30
Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)
National Cancer Institute (NCI)
Phase 2 Completed
NCT00889057 2013-03-28
Sorafenib in Relapsed High Grade Osteosarcoma
Italian Sarcoma Group
Phase 2 Completed